Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Employment agrmnt
Quarterly results
Director comp.

MoonLake Immunotherapeutics Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "MoonLake Immunotherapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update"
06/29/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "MOONLAKE IMMUNOTHERAPEUTICS"
06/07/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/19/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/19/2023 8-K Quarterly results
03/20/2023 8-K Quarterly results
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
06/17/2022 8-K Quarterly results
06/07/2022 8-K Quarterly results
05/16/2022 8-K/A Quarterly results
04/11/2022 8-K Amended existing or entered into new employment agreement with an officer, Director compensation was amended/approved
Docs: "Memorandum and Articles of Association of MoonLake Immunotherapeutics",
"Amended and Restated Shareholders’ Agreement, by and among MoonLake Immunotherapeutics, MoonLake Immunotherapeutics AG and the investors signatory thereto",
"Amended and Restated Registration Rights Agreement, by and among the MoonLake Immunotherapeutics, Helix Holdings LLC and the holders signatory thereto",
"Form of Subscription Agreement",
"MOONLAKE IMMUNOTHERAPEUTICS 2022 EQUITY INCENTIVE PLAN",
"Letter Agreement, among Helix Acquisition Corp., Helix Holdings LLC and each of the officers and directors of Helix (incorporated by reference to of Helix’s Form 8-K, filed with the SEC on October 22, 2020)",
"Code of Business Conduct and Ethics",
"Subsidiaries of MoonLake Immunotherapeutics",
"MoonLake Immunotherapeutics AG Announces Closing of Business Combination with Helix Acquisition Corp.",
"MoonLake Immunotherapeutics unaudited pro forma condensed combined balance sheet as of December 31, 2021 and the unaudited pro forma condensed combined statement of operations for the year ended December 31, 2021"
03/31/2022 8-K Quarterly results
03/24/2022 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial ...
Docs: "PROMISSORY NOTE"
02/25/2022 8-K Quarterly results
12/03/2021 8-K Quarterly results
10/04/2021 8-K Quarterly results
05/03/2021 8-K Quarterly results
02/24/2021 8-K Entry into a Material Definitive Agreement, Other Events
10/28/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "Audited Balance Sheet as of October 22, 2020"
10/22/2020 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...
Docs: "Underwriting Agreement, between the Company and Jefferies LLC",
"Amended and Restated Memorandum and Articles of Association",
"Letter Agreement, among the Company, Helix Holdings LLC and each of the officers and directors of the Company",
"Investment Management Trust Agreement, between the Company and Continental Stock Transfer & Trust Company, as trustee",
"Registration Rights Agreement, among the Company, Helix Holdings LLC and the Holders signatory thereto",
"Private Placement Class A Ordinary Shares Purchase Agreement, between the Company and Helix Holdings LLC",
"Administrative Services Agreement, between the Company and Helix Holdings LLC",
"Press Release",
"EXHIBIT 99.2 Helix Acquisition Corp. Announces Closing of $115 Million Initial Public Offering, Including the Full Exercise of the Underwriter’ s Option to Purchase Additional Shares"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy